PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 224 filers reported holding PROMETHEUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.71 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,055,400 | +8.1% | 28,470 | +10.8% | 0.93% | -18.5% |
| Q4 2022 | $2,827,000 | -61.2% | 25,700 | -79.2% | 1.14% | -42.9% |
| Q3 2022 | $7,294,000 | -18.7% | 123,599 | -61.1% | 2.00% | -45.5% |
| Q2 2022 | $8,970,000 | +59.4% | 317,758 | +113.2% | 3.67% | +67.0% |
| Q1 2022 | $5,629,000 | – | 149,066 | – | 2.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $203,282,640 | 93.46% |
| CHI Advisors LLC | 923,800 | $101,618,000 | 27.06% |
| Sio Capital Management, LLC | 574,200 | $63,162,000 | 23.36% |
| Cormorant Asset Management, LP | 2,090,000 | $229,900 | 15.38% |
| Boxer Capital, LLC | 1,897,500 | $208,725,000 | 11.00% |
| SEVEN GRAND MANAGERS, LLC | 20,105 | $2,211,550 | 10.34% |
| Decheng Capital Management III (Cayman), LLC | 250,000 | $27,500,000 | 10.29% |
| Ikarian Capital, LLC | 288,926 | $31,781,860 | 7.67% |
| RTW INVESTMENTS, LP | 3,354,303 | $368,973,330 | 7.53% |
| Waypoint Capital Advisors, LLC | 171,181 | $18,829,910 | 6.53% |